Bio-Path Holdings (BPTH) has provided an announcement.
Bio-Path Holdings, Inc. has successfully entered into a securities purchase agreement with an institutional investor, raising $4.0 million through a private placement of common stock and various warrants. The company is set to use the proceeds for general corporate purposes and working capital. Investors were offered common stock and pre-funded, series A, and series B warrants at specified prices, with the understanding that they are accredited investors. The deal involved certain fees and warrants for the placement agent, H.C. Wainwright & Co., LLC, and all securities were issued under exemptions from registration requirements.
For a thorough assessment of BPTH stock, go to TipRanks’ Stock Analysis page.
